Brief: Neurovive Pharmaceutical Q3 loss before tax 34.3 mln SEK

Abliva AB

22/11/2016 07:30

Nov 22 (Reuters) - Neurovive Pharmaceutical Ab  NVP.ST  
    * Neurovive pharmaceutical ab says Q3 loss before tax was 
sek 34,290,000 (53,948,000) 
    * Neurovive pharmaceutical ab q3 net revenues were sek 0 (0) 
and other operating income was sek 16,000 (74,000) 
 
Source text for Eikon:  ID:nWkrku9344  
Further company coverage:  NVP.ST  
 
 (Reporting By Anna Ringstrom) 
 ((Anna.Ringstrom@thomsonreuters.com;))